BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 287 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,792,000 | +97.3% | 20,096 | -37.8% | 0.14% | +42.9% |
| Q2 2019 | $1,415,000 | -55.0% | 32,300 | -47.1% | 0.10% | -44.6% |
| Q1 2019 | $3,143,000 | -22.7% | 61,069 | -44.5% | 0.18% | -43.5% |
| Q4 2018 | $4,068,000 | +18.4% | 110,010 | +20.2% | 0.31% | +29.9% |
| Q3 2018 | $3,436,000 | -32.8% | 91,488 | -29.3% | 0.24% | -8.7% |
| Q2 2018 | $5,113,000 | +77.2% | 129,368 | +15.5% | 0.26% | +114.6% |
| Q1 2018 | $2,885,000 | +31.2% | 111,991 | +37.4% | 0.12% | +7.0% |
| Q4 2017 | $2,199,000 | – | 81,497 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |